|
1
|
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
|
JAMA
|
2005
|
7.35
|
|
2
|
Rhythm control versus rate control for atrial fibrillation and heart failure.
|
N Engl J Med
|
2008
|
6.17
|
|
3
|
Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
|
Lancet
|
2007
|
5.06
|
|
4
|
Aortic diameter, wall stiffness, and wave reflection in systolic hypertension.
|
Hypertension
|
2007
|
3.68
|
|
5
|
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
|
JACC Cardiovasc Imaging
|
2008
|
2.24
|
|
6
|
Heart failure clinics and outpatient management: review of the evidence and call for quality assurance.
|
Eur Heart J
|
2004
|
2.20
|
|
7
|
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
|
Can J Cardiol
|
2012
|
1.86
|
|
8
|
Augmentation index and central aortic stiffness in middle-aged to elderly individuals.
|
Am J Hypertens
|
2007
|
1.85
|
|
9
|
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
|
Can J Cardiol
|
2013
|
1.85
|
|
10
|
Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
|
CMAJ
|
2012
|
1.84
|
|
11
|
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America.
|
Circulation
|
2005
|
1.78
|
|
12
|
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.
|
Can J Cardiol
|
2011
|
1.78
|
|
13
|
Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
|
Nephrol Dial Transplant
|
2007
|
1.67
|
|
14
|
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
|
Circulation
|
2005
|
1.59
|
|
15
|
Are subjects satisfied with the informed consent process? A survey of research participants.
|
J Rheumatol
|
2003
|
1.57
|
|
16
|
On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada.
|
Can J Cardiol
|
2003
|
1.54
|
|
17
|
Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
|
Circulation
|
2005
|
1.47
|
|
18
|
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.
|
Can J Cardiol
|
2012
|
1.44
|
|
19
|
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
|
Can J Cardiol
|
2010
|
1.44
|
|
20
|
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.
|
Can J Cardiol
|
2011
|
1.38
|
|
21
|
Rac1 is required for cardiomyocyte apoptosis during hyperglycemia.
|
Diabetes
|
2009
|
1.38
|
|
22
|
Treating the right patient at the right time: access to heart failure care.
|
Can J Cardiol
|
2006
|
1.36
|
|
23
|
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study.
|
J Am Coll Cardiol
|
2003
|
1.32
|
|
24
|
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy.
|
Hypertension
|
2007
|
1.29
|
|
25
|
Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease.
|
Circulation
|
2007
|
1.24
|
|
26
|
Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes.
|
Diabetes
|
2010
|
1.20
|
|
27
|
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
|
Eur Heart J
|
2008
|
1.16
|
|
28
|
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.
|
J Am Coll Cardiol
|
2007
|
1.13
|
|
29
|
Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
|
Eur Heart J
|
2007
|
1.11
|
|
30
|
Taurine prevents cardiomyocyte death by inhibiting NADPH oxidase-mediated calpain activation.
|
Free Radic Biol Med
|
2008
|
1.07
|
|
31
|
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.
|
Can J Cardiol
|
2009
|
1.04
|
|
32
|
Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition.
|
Hypertension
|
2005
|
1.00
|
|
33
|
Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study.
|
J Am Soc Echocardiogr
|
2006
|
0.96
|
|
34
|
Improving the continuity of care following discharge of patients hospitalized with heart failure: is the discharge summary adequate?
|
Can J Cardiol
|
2003
|
0.96
|
|
35
|
Disruption of Rac1 signaling reduces ischemia-reperfusion injury in the diabetic heart by inhibiting calpain.
|
Free Radic Biol Med
|
2010
|
0.93
|
|
36
|
Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure.
|
Am Heart J
|
2005
|
0.87
|
|
37
|
Alpha-1 adrenoceptor hyperresponsiveness in three neuropathic pain states: complex regional pain syndrome 1, diabetic peripheral neuropathic pain and central pain states following spinal cord injury.
|
Pain Res Manag
|
2004
|
0.85
|
|
38
|
Value of the electrocardiogram in predicting left ventricular enlargement and dysfunction after myocardial infarction.
|
Am J Med
|
2003
|
0.85
|
|
39
|
Instruments to measure acceptability of information and acquisition of knowledge in patients with heart failure.
|
Eur J Heart Fail
|
2003
|
0.83
|
|
40
|
Disruption of phospholipase Cgamma1 signalling attenuates cardiac tumor necrosis factor-alpha expression and improves myocardial function during endotoxemia.
|
Cardiovasc Res
|
2007
|
0.83
|
|
41
|
Recombinant human annexin A5 inhibits proinflammatory response and improves cardiac function and survival in mice with endotoxemia.
|
Crit Care Med
|
2014
|
0.82
|
|
42
|
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM Program.
|
Eur J Heart Fail
|
2005
|
0.82
|
|
43
|
Role of tumor necrosis factor-alpha in myocardial dysfunction and apoptosis during hindlimb ischemia and reperfusion.
|
Crit Care Med
|
2006
|
0.78
|
|
44
|
Acute decompensated heart failure: the quest to live longer and feel better: can we have it all?
|
J Am Coll Cardiol
|
2012
|
0.77
|
|
45
|
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension.
|
Am Heart J
|
2006
|
0.77
|
|
46
|
The art and science of heart failure: predicting the unpredictable.
|
J Am Coll Cardiol
|
2010
|
0.75
|
|
47
|
Novel risk factors for heart failure when the whole may be greater than the sum of its parts.
|
J Am Coll Cardiol
|
2009
|
0.75
|
|
48
|
Caring for patients with heart failure.
|
Can Nurse
|
2006
|
0.75
|
|
49
|
Effects of enalaprilat on venoconstriction to norepinephrine: role of prostaglandins.
|
Cardiovasc Res
|
2003
|
0.75
|
|
50
|
Prostaglandin modulation of venoconstriction to physiological stress in normals and heart failure patients.
|
Am J Physiol Heart Circ Physiol
|
2003
|
0.75
|